These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 8562262)
1. [PLasma lipids and cardiovascular risk: lesions in the community]. Farinaro E; Della Valle E; Ferrantino G Ann Ital Med Int; 1995 Oct; 10 Suppl():31S-34S. PubMed ID: 8562262 [TBL] [Abstract][Full Text] [Related]
2. [Cardiovascular risk factors and prevention in women: similarities and differences]. Sclavo M Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880 [TBL] [Abstract][Full Text] [Related]
3. Serum lipid profiles and risk of cardiovascular disease in three different male populations in northern Nigeria. Glew RH; Kassam HA; Bhanji RA; Okorodudu A; VanderJagt DJ J Health Popul Nutr; 2002 Jun; 20(2):166-74. PubMed ID: 12186197 [TBL] [Abstract][Full Text] [Related]
4. Risk factors for cardiovascular disease and diet of urban and rural dwellers in northern Nigeria. Glew RH; Conn CA; Vanderjagt TA; Calvin CD; Obadofin MO; Crossey M; Vanderjagt DJ J Health Popul Nutr; 2004 Dec; 22(4):357-69. PubMed ID: 15663169 [TBL] [Abstract][Full Text] [Related]
5. Effect of red wine and red grape extract on blood lipids, haemostatic factors, and other risk factors for cardiovascular disease. Hansen AS; Marckmann P; Dragsted LO; Finné Nielsen IL; Nielsen SE; Grønbaek M Eur J Clin Nutr; 2005 Mar; 59(3):449-55. PubMed ID: 15674304 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular risk factors in obese women and their first-degree relatives. Saraç F; Ozgen AG; Yilmaz C; Tüzün M Anadolu Kardiyol Derg; 2007 Dec; 7(4):371-7. PubMed ID: 18065331 [TBL] [Abstract][Full Text] [Related]
8. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk. Robinson JG Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323 [TBL] [Abstract][Full Text] [Related]
9. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Hadaegh F; Harati H; Ghanbarian A; Azizi F Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):571-7. PubMed ID: 16874147 [TBL] [Abstract][Full Text] [Related]
10. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis]. Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811 [TBL] [Abstract][Full Text] [Related]
11. Lipid levels and cardiovascular risk in elderly women: a general population study of the effects of hormonal treatment and lipid-lowering agents. Dupuy AM; Carrière I; Scali J; Cristol JP; Ritchie K; Dartigues JF; Gambert P; Ancelin ML Climacteric; 2008 Feb; 11(1):74-83. PubMed ID: 18202967 [TBL] [Abstract][Full Text] [Related]
12. Total and regional fat and serum cardiovascular disease risk factors in lean and obese children and adolescents. Teixeira PJ; Sardinha LB; Going SB; Lohman TG Obes Res; 2001 Aug; 9(8):432-42. PubMed ID: 11500523 [TBL] [Abstract][Full Text] [Related]
13. Incidence of cardiovascular risk factors and complications before and after kidney transplantation. Fazelzadeh A; Mehdizadeh A; Ostovan MA; Raiss-Jalali GA Transplant Proc; 2006 Mar; 38(2):506-8. PubMed ID: 16549161 [TBL] [Abstract][Full Text] [Related]
14. Investigation of lipids. What do the results really mean? Sullivan D Aust Fam Physician; 2000 Mar; 29(3):207-11. PubMed ID: 10785985 [TBL] [Abstract][Full Text] [Related]
15. The association of cardiovascular disease risk factors with abdominal obesity in Canada. Canadian Heart Health Surveys Research Group. Reeder BA; Senthilselvan A; Després JP; Angel A; Liu L; Wang H; Rabkin SW CMAJ; 1997 Jul; 157 Suppl 1():S39-45. PubMed ID: 9220953 [TBL] [Abstract][Full Text] [Related]
16. [Decisions regarding cholesterol-lowering therapy in the elderly: the experience in a lipid clinic and a review of the literature]. Garrido Sanjuán JA; Pía Iglesias G; González Moraleja J; Sesma P An Med Interna; 1998 Jun; 15(6):305-10. PubMed ID: 9656510 [TBL] [Abstract][Full Text] [Related]
17. Plasma lipids and lipoprotein alterations in tamoxifen-treated breast cancer women in relation to the menopausal status. Ilanchezhian S; Thangaraju M; Sachdanandam P Cancer Biochem Biophys; 1995 Nov; 15(2):83-90. PubMed ID: 8590439 [TBL] [Abstract][Full Text] [Related]
18. Relationship between gamma-glutamyltransferase, lipids and lipoprotein(a) in the general population. Lippi G; Targher G; Montagnana M; Salvagno GL; Guidi GC Clin Chim Acta; 2007 Sep; 384(1-2):163-6. PubMed ID: 17601521 [TBL] [Abstract][Full Text] [Related]
19. [Pathophysiologic aspects of hyperlipoproteinemias]. Soska V Vnitr Lek; 2000 Sep; 46(9):506-9. PubMed ID: 11344641 [TBL] [Abstract][Full Text] [Related]
20. Distribution of risk factors, plasma lipids, lipoproteins and dyslipidemias in a small Mediterranean island: the Ustica Project. Barbagallo CM; Polizzi F; Severino M; Onorato F; Noto D; Cefalù AB; Rizzo M; Notarbartolo A; Averna MR Nutr Metab Cardiovasc Dis; 2002 Oct; 12(5):267-74. PubMed ID: 12616806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]